{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:52:04Z","timestamp":1786373524230,"version":"build-2736575974"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2016,9]]},"abstract":"\n Background and objectives<\/jats:title>\n In the general population, the presence of cerebral microbleeds on T2*\u2013weighted magnetic resonance imaging has been reported to be a predictor of future stroke. Patients with CKD have a high prevalence of microbleeds and are at higher risk of ESRD as well as cardiovascular disease, including stroke. Because endothelial dysfunction is the common pathophysiology among microbleeds, CKD, and cardiovascular disease, we hypothesized that the presence of microbleeds would be an important predictor of composite outcome, including both cardiovascular disease and renal events, in those with CKD.<\/jats:p>\n <\/jats:sec>\n \n Design, settings, participants, & measurements<\/jats:title>\n This was a prospective cohort study of 404 patients with CKD who underwent T2*\u2013weighted magnetic resonance imaging for this study between January of 2008 and January of 2011. The primary outcome was composite of cardiovascular and renal outcomes. Cardiovascular outcomes included cardiovascular death, the new onset of myocardial infarction, coronary revascularization, stroke, and amputation\/revascularization because of peripheral artery disease. Renal outcomes included doubling of the serum creatinine level and development of ESRD requiring dialysis or transplantation.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n At baseline, microbleeds were present in 83 (20.5%) patients. During the follow-up median period of 2.3 years, 124 of the 404 patients experienced the composite outcome. The presence of microbleeds was associated with higher risk for the composite outcome in an unadjusted Cox model, and it remained significant after adjustment for age, sex, diabetes, and systolic BP (hazard ratio [HR], 2.58; 95% confidence interval [95% CI], 1.68 to 3.46 for composite outcome; hazard ratio, 2.41; 95% CI, 1.55 to 3.77 for renal outcome; hazard ratio, 3.46; 95% CI, 1.62 to 7.43 for cardiovascular disease outcome).<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n In patients with CKD, the presence of microbleeds is a novel and independent predictor of both renal and cardiovascular disease end points.<\/jats:p>\n <\/jats:sec>","DOI":"10.2215\/cjn.13481215","type":"journal-article","created":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T12:24:30Z","timestamp":1467203070000},"page":"1557-1565","source":"Crossref","is-referenced-by-count":14,"title":["Silent Cerebral Microbleeds and Longitudinal Risk of Renal and Cardiovascular Events in Patients with CKD"],"prefix":"10.2215","volume":"11","author":[{"given":"Hideaki","family":"Shima","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuhiko","family":"Mori","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Ooi","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Sonoda","sequence":"additional","affiliation":[{"name":"Endocrinology, Metabolism and Molecular Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Shoji","sequence":"additional","affiliation":[{"name":"Vascular Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Ishimura","sequence":"additional","affiliation":[{"name":"Nephrology, Osaka City University Graduate School of Medicine, Osaka, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Okamura","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Ohno Memorial Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobukazu","family":"Ishizaka","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Osaka Medical College, Takatsuki, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Inaba","sequence":"additional","affiliation":[{"name":"Endocrinology, Metabolism and Molecular Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2016,6,27]]},"reference":[{"key":"B1-20230813","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/01.ASN.0000123691.46138.E2","article-title":"Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies.","volume":"15","author":"Weiner","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"B2-20230813","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"key":"B3-20230813","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0272-6386(03)00916-8","article-title":"A population-based study of the incidence and outcomes of diagnosed chronic kidney disease.","volume":"42","author":"Drey","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"B4-20230813","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1681\/ASN.V133745","article-title":"Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States.","volume":"13","author":"Muntner","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"B5-20230813","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1046\/j.1523-1755.2003.00109.x","article-title":"Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: The ARIC Study.","volume":"64","author":"Abramson","year":"2003","journal-title":"Kidney Int"},{"key":"B6-20230813","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/ndt\/gfr218","article-title":"Incidence of stroke symptoms among adults with chronic kidney disease: Results from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.","volume":"27","author":"Muntner","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"B7-20230813","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1161\/hs0102.101792","article-title":"Magnetic resonance imaging detection of microbleeds before thrombolysis: An emerging application.","volume":"33","author":"Kidwell","year":"2002","journal-title":"Stroke"},{"key":"B8-20230813","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/ndt\/gfp694","article-title":"Cerebral microbleeds in predialysis patients with chronic kidney disease.","volume":"25","author":"Shima","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"B9-20230813","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1007\/s00415-015-7840-2","article-title":"Renal dysfunction is associated with deep cerebral microbleeds but not white matter hyperintensities in patients with acute intracerebral hemorrhage.","volume":"262","author":"Laible","year":"2015","journal-title":"J Neurol"},{"key":"B10-20230813","first-page":"585","article-title":"Evidence-based clinical practice guideline for CKD.","volume":"55","year":"2016","journal-title":"Clin Exp Nephrol"},{"key":"B11-20230813","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1053\/j.ajkd.2007.09.004","article-title":"Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan.","volume":"50","author":"Imai","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"B12-20230813","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","article-title":"Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.","volume":"20","year":"1997","journal-title":"Diabetes Care"},{"key":"B13-20230813","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO).","volume":"67","author":"Levey","year":"2005","journal-title":"Kidney Int"},{"key":"B14-20230813","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1212\/01.wnl.0000194266.55694.1e","article-title":"Cerebral microbleeds on MRI: Prevalence, associations, and potential clinical implications.","volume":"66","author":"Koennecke","year":"2006","journal-title":"Neurology"},{"key":"B15-20230813","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/01.STR.0000199847.96188.12","article-title":"Cerebral microhemorrhage.","volume":"37","author":"Viswanathan","year":"2006","journal-title":"Stroke"},{"key":"B16-20230813","doi-asserted-by":"crossref","first-page":"346","DOI":"10.5414\/CNP75346","article-title":"Factors associated with silent cerebral microbleeds in hemodialysis patients.","volume":"75","author":"Naganuma","year":"2011","journal-title":"Clin Nephrol"},{"key":"B17-20230813","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1161\/STROKEAHA.110.588020","article-title":"Microbleeds and the risk of recurrent stroke.","volume":"41","author":"Thijs","year":"2010","journal-title":"Stroke"},{"key":"B18-20230813","first-page":"830","article-title":"Combinations of the presence or absence of cerebral microbleeds and advanced white matter hyperintensity as predictors of subsequent stroke types.","volume":"27","author":"Naka","year":"2006","journal-title":"AJNR Am J Neuroradiol"},{"key":"B19-20230813","first-page":"637","article-title":"Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: Evidence of microangiopathy-related microbleeds.","volume":"20","author":"Fazekas","year":"1999","journal-title":"AJNR Am J Neuroradiol"},{"key":"B20-20230813","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1161\/01.STR.0000018012.65108.86","article-title":"Silent cerebral microbleeds on T2*-weighted MRI: Correlation with stroke subtype, stroke recurrence, and leukoaraiosis.","volume":"33","author":"Kato","year":"2002","journal-title":"Stroke"},{"key":"B21-20230813","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1161\/01.STR.31.7.1646","article-title":"Assessment of lacunar hemorrhage associated with hypertensive stroke by echo-planar gradient-echo T2*-weighted MRI.","volume":"31","author":"Kinoshita","year":"2000","journal-title":"Stroke"},{"key":"B22-20230813","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/hr.2008.27","article-title":"Strain vessel hypothesis: A viewpoint for linkage of albuminuria and cerebro-cardiovascular risk.","volume":"32","author":"Ito","year":"2009","journal-title":"Hypertens Res"},{"key":"B23-20230813","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1503\/jpn.140334","article-title":"Association between arterial stiffness, depressive symptoms and cerebral small vessel disease; cross-sectional findings from the AGE-Reykjavik Study.","volume":"41","author":"Van Sloten","year":"2016","journal-title":"J Psychiatry Neurosci"},{"key":"B24-20230813","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1681\/ASN.V12102117","article-title":"Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease.","volume":"12","author":"Shoji","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"B25-20230813","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.2215\/CJN.03000315","article-title":"Arterial stiffness and decline in kidney function.","volume":"10","author":"Sedaghat","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"B26-20230813","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2009050558","article-title":"Cerebral microvascular disease predicts renal failure in type 2 diabetes.","volume":"21","author":"Uzu","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B27-20230813","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/ndt\/gfn419","article-title":"Relationship between silent brain infarction and chronic kidney disease.","volume":"24","author":"Kobayashi","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"B28-20230813","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: The Mild to Moderate Kidney Disease (MMKD) Study.","volume":"18","author":"Fliser","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"B29-20230813","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jama.2011.308","article-title":"Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: A systematic review and meta-analysis.","volume":"305","author":"Palmer","year":"2011","journal-title":"JAMA"},{"key":"B30-20230813","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/archinte.167.9.879","article-title":"Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community.","volume":"167","author":"Dhingra","year":"2007","journal-title":"Arch Intern Med"},{"key":"B31-20230813","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1093\/ndt\/gfq808","article-title":"Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease.","volume":"26","author":"O\u2019Seaghdha","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"B32-20230813","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.","volume":"119","author":"Guti\u00e9rrez","year":"2009","journal-title":"Circulation"},{"key":"B33-20230813","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy.","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201609000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:46:38Z","timestamp":1786369598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201609000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,27]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.13481215","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,27]]}}}